Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-24-024711

Options or other derivatives

  • Director acquired 127,805 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gangolli Julian S Director 2024-10-01 Grant or award · Stock Option (Right to Buy) +56,636 56,636 D: show line 1 in the form
Gangolli Julian S Director 2024-10-01 Grant or award · Stock Option (Right to Buy) +71,169 71,169 D: show line 2 in the form
Loading xslF345X05/form4-10042024_011036.xml…